Weight loss compounded tirzepatide

Compounded tirzepatide has been a popular, more affordable alternative to brand-name weight-loss medications like Zepbound and Mounjaro. However, its availability is now extremely limited following the resolution of the national drug shortage.

Compounded tirzepatide is a custom-made version of the medication created by a licensed pharmacy when the FDA-approved version (Zepbound or Mounjaro) is in shortage . It contains the same active ingredient but is not FDA-approved, meaning its safety, effectiveness, and quality have not been evaluated by the agency .

The primary reason for its use has been lower cost. Compounded versions have typically cost between $100 and $300 per month, while brand-name drugs can exceed $1,000 .

Compounded tirzepatide is no longer legally available for most patients. The FDA declared the shortage of tirzepatide injections resolved in October 2024 . This decision was upheld in December 2024, and the grace periods for pharmacies to stop production have since passed .

Current exceptions: Compounding is only allowed in very limited circumstances, such as when a patient has a specific medical need—for example, an allergy to an ingredient in the FDA-approved drug. Cost alone is not considered a valid reason for compounding .

If you were previously using a compounded version, you should talk to your healthcare provider about transitioning to an FDA-approved option like Zepbound or Mounjaro .

Despite the lack of FDA review, some real-world studies and patient reports show that compounded tirzepatide has been effective for weight loss.

• Significant results: A study of 50 patients in a cardiometabolic clinic found an average weight loss of 16 pounds at 12 weeks and nearly 39 pounds at 24 weeks .
• Individual experiences: Many patients have reported substantial weight loss, with one person losing 36 pounds in three months .

However, the results can be inconsistent. A small case study noted that while a user lost 5% of their body weight in four weeks, they quickly regained it after stopping the medication .

Because compounded tirzepatide is not FDA-regulated, it carries unique risks that you should carefully consider.

• Lack of standardization: Unlike the brand-name drug, the dosage and ingredients can vary between pharmacies, and there is no standard package insert with safety information .
• Risk of contamination: Improper sterile practices at a compounding facility can lead to contaminated products .
• Counterfeit products: Illegal and counterfeit versions are sold online, sometimes containing the wrong dose, no active ingredient, or other dangerous substances .

Common side effects are similar to those of the brand-name drug and are mostly gastrointestinal, including nausea, vomiting, diarrhea, and constipation .

Here are the steps you should take to safely continue or begin treatment with tirzepatide.

• Consult your doctor: Discuss the transition from a compounded formula to an FDA-approved prescription for either weight management (Zepbound) or type 2 diabetes (Mounjaro) .
• Explore cost assistance: If cost is a barrier, ask your doctor about manufacturer savings cards, patient assistance programs, or check with different pharmacies for cash-pay options.
• Verify your medication: If you do obtain a compounded version, use only a state-licensed pharmacy or an FDA-registered outsourcing facility . Be extremely cautious of any seller that does not require a prescription .